Related Experiment Video
Updated: Jun 17, 2025

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Pathophysiology of Cystic Fibrosis Liver Disease
Vania L Kasper1, David N Assis2
1The Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Hasbro Children's Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Insights
Cystic Fibrosis (CF) can cause serious liver and bile duct problems, leading to death in advanced cases. Understanding CF
Area of Science:
- Hepatology and Gastroenterology
- Genetics and Molecular Biology
- Pulmonology and Respiratory Medicine
Background:
- Hepatobiliary complications are a major health burden in Cystic Fibrosis (CF).
- Advanced CF liver disease is a leading cause of mortality among CF patients.
- The diverse clinical presentations, from steatosis to biliary strictures, have poorly understood origins.
Purpose of the Study:
- To review the current understanding of the pathophysiology of hepatobiliary manifestations in CF.
- To discuss emerging disease models for CF-related liver disease.
- To explore promising therapeutic strategies for this aspect of CF care.
Main Methods:
- Literature review of existing research on CF hepatobiliary complications.
- Analysis of current knowledge on CFTR mutations and their impact on liver health.
- Examination of novel preclinical and clinical studies on CF liver disease.
Main Results:
- Hepatobiliary complications in CF are complex and multifactorial.
- Underlying CFTR mutations interact with environmental and modifying factors.
- Current understanding of pathophysiology is incomplete, necessitating further research.
- Emerging models and therapies show potential for improved patient outcomes.
Conclusions:
- Hepatobiliary manifestations are a critical concern in CF care.
- Further research into pathophysiology and therapeutic targets is essential.
- Improved understanding and treatment of CF liver disease can reduce mortality.
Abstract:
Hepatobiliary complications of Cystic Fibrosis (CF) constitute a significant burden for persons with CF of all ages, with advanced CF liver disease in particular representing a leading cause of mortality. The causes of the heterogeneity of clinical manifestations, ranging from steatosis to focal biliary cholestasis and biliary strictures, are poorly understood and likely reflect a variety of environmental and disease-modifying factors in the setting of underlying CFTR mutations. This review summarizes the current understanding of the pathophysiology of hepatobiliary manifestations of CF, and discusses emerging disease models and therapeutic approaches that hold promise to impact this important yet incompletely addressed aspect of CF care.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

